Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Buisson

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 20, 2001
Neuroprotection mediated by glial cell line-derived neurotrophic factor: involvement of a reduction of NMDA-induced calcium influx by the mitogen-activated protein kinase pathwayO Nicole, C Ali, F Docagne, et al.
Neuroreport|February 24, 2001
Complement anaphylatoxin C3a is selectively protective against NMDA-induced neuronal cell deathJ van Beek, O Nicole, C Ali, et al.
Journal of Crohn'S & Colitis|September 10, 2015
Endoscopic Factors Influencing Fecal Calprotectin Value in Crohn's DiseaseF Goutorbe, M Goutte, R Minet-Quinard, et al.
Gynecologie, Obstetrique, Fertilite & Senologie|August 17, 2021
[Giant condyloma acuminatum in pregnancy]D Riethmuller, A Buisson, C Thong Vanh, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|July 14, 2000
Ischemia-induced interleukin-6 as a potential endogenous neuroprotective cytokine against NMDA receptor-mediated excitotoxicity in the brainC Ali, O Nicole, F Docagne, et al.
Nature Medicine|January 3, 2001
The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signalingO Nicole, F Docagne, C Ali, et al.
Journal of Neurochemistry|October 3, 2007
Comparison of the pharmacological properties of GK11 and MK801, two NMDA receptor antagonists: towards an explanation for the lack of intrinsic neurotoxicity of GK11D Vandame, G Desmadryl, J Becerril Ortega, et al.
Alimentary Pharmacology & Therapeutics|December 1, 2023
Long-term effectiveness and acceptability of switching from intravenous to subcutaneous infliximab in patients with inflammatory bowel disease treated with intensified doses: The REMSWITCH-LT studyA Buisson, M Nachury, M Bazoge, et al.
Alimentary Pharmacology & Therapeutics|April 4, 2012
Methotrexate for psoriasiform lesions associated with anti-tumour necrosis factor therapy in inflammatory bowel diseaseA Buisson, J-F Cuny, A Barbaud, et al.
Alimentary Pharmacology & Therapeutics|March 9, 2016
Faecal chitinase 3-like 1 is a reliable marker as accurate as faecal calprotectin in detecting endoscopic activity in adult patients with inflammatory bowel diseasesA Buisson, E Vazeille, R Minet-Quinard, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 20, 2001
Neuroprotection mediated by glial cell line-derived neurotrophic factor: involvement of a reduction of NMDA-induced calcium influx by the mitogen-activated protein kinase pathwayO Nicole, C Ali, F Docagne, et al.
Neuroreport|February 24, 2001
Complement anaphylatoxin C3a is selectively protective against NMDA-induced neuronal cell deathJ van Beek, O Nicole, C Ali, et al.
Journal of Crohn'S & Colitis|September 10, 2015
Endoscopic Factors Influencing Fecal Calprotectin Value in Crohn's DiseaseF Goutorbe, M Goutte, R Minet-Quinard, et al.
Gynecologie, Obstetrique, Fertilite & Senologie|August 17, 2021
[Giant condyloma acuminatum in pregnancy]D Riethmuller, A Buisson, C Thong Vanh, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|July 14, 2000
Ischemia-induced interleukin-6 as a potential endogenous neuroprotective cytokine against NMDA receptor-mediated excitotoxicity in the brainC Ali, O Nicole, F Docagne, et al.
Nature Medicine|January 3, 2001
The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signalingO Nicole, F Docagne, C Ali, et al.
Journal of Neurochemistry|October 3, 2007
Comparison of the pharmacological properties of GK11 and MK801, two NMDA receptor antagonists: towards an explanation for the lack of intrinsic neurotoxicity of GK11D Vandame, G Desmadryl, J Becerril Ortega, et al.
Alimentary Pharmacology & Therapeutics|December 1, 2023
Long-term effectiveness and acceptability of switching from intravenous to subcutaneous infliximab in patients with inflammatory bowel disease treated with intensified doses: The REMSWITCH-LT studyA Buisson, M Nachury, M Bazoge, et al.
Alimentary Pharmacology & Therapeutics|April 4, 2012
Methotrexate for psoriasiform lesions associated with anti-tumour necrosis factor therapy in inflammatory bowel diseaseA Buisson, J-F Cuny, A Barbaud, et al.
Alimentary Pharmacology & Therapeutics|March 9, 2016
Faecal chitinase 3-like 1 is a reliable marker as accurate as faecal calprotectin in detecting endoscopic activity in adult patients with inflammatory bowel diseasesA Buisson, E Vazeille, R Minet-Quinard, et al.
Pageof 5